Selected research
Industry Growth & Trends
Global Acetylglucosamine Industry Growth and Trends Forecast to 2032
Market perspective
The global Acetylglucosamine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Acetylglucosamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Acetylglucosamine include YSK, Fengrun Biotech, Golden-shell, Aoxin-group, Rixing Biotech, Bio-gen Extracts, AdvoCare, Amicogen and Merck KGaA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Acetylglucosamine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Acetylglucosamine market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acetylglucosamine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acetylglucosamine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Acetylglucosamine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Acetylglucosamine Market by Company
YSK
Fengrun Biotech
Golden-shell
Aoxin-group
Rixing Biotech
Bio-gen Extracts
AdvoCare
Amicogen
Merck KGaA
Carl Roth
Kaneka
Ethical Naturals
NOW Foods
Beloor Bayir
Vitaco Health
Pure Encapsulations
Kraeber & Co
Source Naturals
NutriCology
Acetylglucosamine Segment by Type
Extraction of the Shell
Microbial Fermentation
Acetylglucosamine Segment by Application
Cosmetics
Health Care Products
Drugs
Others
Acetylglucosamine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acetylglucosamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acetylglucosamine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acetylglucosamine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acetylglucosamine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Acetylglucosamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Extraction of the Shell
- Microbial Fermentation
Applications
- Cosmetics
- Health Care Products
- Drugs
- Others
Companies covered
- YSK
- Fengrun Biotech
- Golden-shell
- Aoxin-group
- Rixing Biotech
- Bio-gen Extracts
- AdvoCare
- Amicogen
- Merck KGaA
- Carl Roth
- Kaneka
- Ethical Naturals
- NOW Foods
- Beloor Bayir
- Vitaco Health
- Pure Encapsulations
- Kraeber & Co
- Source Naturals
- NutriCology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Acetylglucosamine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Acetylglucosamine Sales Estimates and Forecasts (2021-2032)
- 1.3 Acetylglucosamine Market by Type
- 1.3.1 Extraction of the Shell
- 1.3.2 Microbial Fermentation
- 1.4 Global Acetylglucosamine Market Size by Type
- 1.4.1 Global Acetylglucosamine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Acetylglucosamine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Acetylglucosamine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Acetylglucosamine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Acetylglucosamine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Acetylglucosamine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Acetylglucosamine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Acetylglucosamine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Acetylglucosamine Industry Trends
- 2.2 Acetylglucosamine Industry Drivers
- 2.3 Acetylglucosamine Industry Opportunities and Challenges
- 2.4 Acetylglucosamine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Acetylglucosamine Revenue (2021-2026)
- 3.2 Global Top Players by Acetylglucosamine Sales (2021-2026)
- 3.3 Global Top Players by Acetylglucosamine Price (2021-2026)
- 3.4 Global Acetylglucosamine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Acetylglucosamine Major Company Production Sites & Headquarters
- 3.6 Global Acetylglucosamine Company, Product Type & Application
- 3.7 Global Acetylglucosamine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Acetylglucosamine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Acetylglucosamine Players Market Share by Revenue in 2025
- 3.8.3 2025 Acetylglucosamine Tier 1, Tier 2, and Tier 3
4 Acetylglucosamine Regional Status and Outlook
- 4.1 Global Acetylglucosamine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Acetylglucosamine Historic Market Size by Region
- 4.2.1 Global Acetylglucosamine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Acetylglucosamine Sales in Value by Region (2021-2026)
- 4.2.3 Global Acetylglucosamine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Acetylglucosamine Forecasted Market Size by Region
- 4.3.1 Global Acetylglucosamine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Acetylglucosamine Sales in Value by Region (2027-2032)
- 4.3.3 Global Acetylglucosamine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Acetylglucosamine by Application
- 5.1 Acetylglucosamine Market by Application
- 5.1.1 Cosmetics
- 5.1.2 Health Care Products
- 5.1.3 Drugs
- 5.1.4 Others
- 5.2 Global Acetylglucosamine Market Size by Application
- 5.2.1 Global Acetylglucosamine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Acetylglucosamine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Acetylglucosamine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Acetylglucosamine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Acetylglucosamine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Acetylglucosamine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Acetylglucosamine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Acetylglucosamine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 YSK
- 6.1.1 YSK Company Information
- 6.1.2 YSK Business Overview
- 6.1.3 YSK Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 YSK Acetylglucosamine Product Portfolio
- 6.1.5 YSK Recent Developments
- 6.2 Fengrun Biotech
- 6.2.1 Fengrun Biotech Company Information
- 6.2.2 Fengrun Biotech Business Overview
- 6.2.3 Fengrun Biotech Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Fengrun Biotech Acetylglucosamine Product Portfolio
- 6.2.5 Fengrun Biotech Recent Developments
- 6.3 Golden-shell
- 6.3.1 Golden-shell Company Information
- 6.3.2 Golden-shell Business Overview
- 6.3.3 Golden-shell Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Golden-shell Acetylglucosamine Product Portfolio
- 6.3.5 Golden-shell Recent Developments
- 6.4 Aoxin-group
- 6.4.1 Aoxin-group Company Information
- 6.4.2 Aoxin-group Business Overview
- 6.4.3 Aoxin-group Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Aoxin-group Acetylglucosamine Product Portfolio
- 6.4.5 Aoxin-group Recent Developments
- 6.5 Rixing Biotech
- 6.5.1 Rixing Biotech Company Information
- 6.5.2 Rixing Biotech Business Overview
- 6.5.3 Rixing Biotech Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Rixing Biotech Acetylglucosamine Product Portfolio
- 6.5.5 Rixing Biotech Recent Developments
- 6.6 Bio-gen Extracts
- 6.6.1 Bio-gen Extracts Company Information
- 6.6.2 Bio-gen Extracts Business Overview
- 6.6.3 Bio-gen Extracts Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Bio-gen Extracts Acetylglucosamine Product Portfolio
- 6.6.5 Bio-gen Extracts Recent Developments
- 6.7 AdvoCare
- 6.7.1 AdvoCare Company Information
- 6.7.2 AdvoCare Business Overview
- 6.7.3 AdvoCare Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 AdvoCare Acetylglucosamine Product Portfolio
- 6.7.5 AdvoCare Recent Developments
- 6.8 Amicogen
- 6.8.1 Amicogen Company Information
- 6.8.2 Amicogen Business Overview
- 6.8.3 Amicogen Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Amicogen Acetylglucosamine Product Portfolio
- 6.8.5 Amicogen Recent Developments
- 6.9 Merck KGaA
- 6.9.1 Merck KGaA Company Information
- 6.9.2 Merck KGaA Business Overview
- 6.9.3 Merck KGaA Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Merck KGaA Acetylglucosamine Product Portfolio
- 6.9.5 Merck KGaA Recent Developments
- 6.10 Carl Roth
- 6.10.1 Carl Roth Company Information
- 6.10.2 Carl Roth Business Overview
- 6.10.3 Carl Roth Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Carl Roth Acetylglucosamine Product Portfolio
- 6.10.5 Carl Roth Recent Developments
- 6.11 Kaneka
- 6.11.1 Kaneka Company Information
- 6.11.2 Kaneka Business Overview
- 6.11.3 Kaneka Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Kaneka Acetylglucosamine Product Portfolio
- 6.11.5 Kaneka Recent Developments
- 6.12 Ethical Naturals
- 6.12.1 Ethical Naturals Company Information
- 6.12.2 Ethical Naturals Business Overview
- 6.12.3 Ethical Naturals Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Ethical Naturals Acetylglucosamine Product Portfolio
- 6.12.5 Ethical Naturals Recent Developments
- 6.13 NOW Foods
- 6.13.1 NOW Foods Company Information
- 6.13.2 NOW Foods Business Overview
- 6.13.3 NOW Foods Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 NOW Foods Acetylglucosamine Product Portfolio
- 6.13.5 NOW Foods Recent Developments
- 6.14 Beloor Bayir
- 6.14.1 Beloor Bayir Company Information
- 6.14.2 Beloor Bayir Business Overview
- 6.14.3 Beloor Bayir Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Beloor Bayir Acetylglucosamine Product Portfolio
- 6.14.5 Beloor Bayir Recent Developments
- 6.15 Vitaco Health
- 6.15.1 Vitaco Health Company Information
- 6.15.2 Vitaco Health Business Overview
- 6.15.3 Vitaco Health Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Vitaco Health Acetylglucosamine Product Portfolio
- 6.15.5 Vitaco Health Recent Developments
- 6.16 Pure Encapsulations
- 6.16.1 Pure Encapsulations Company Information
- 6.16.2 Pure Encapsulations Business Overview
- 6.16.3 Pure Encapsulations Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Pure Encapsulations Acetylglucosamine Product Portfolio
- 6.16.5 Pure Encapsulations Recent Developments
- 6.17 Kraeber & Co
- 6.17.1 Kraeber & Co Company Information
- 6.17.2 Kraeber & Co Business Overview
- 6.17.3 Kraeber & Co Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Kraeber & Co Acetylglucosamine Product Portfolio
- 6.17.5 Kraeber & Co Recent Developments
- 6.18 Source Naturals
- 6.18.1 Source Naturals Company Information
- 6.18.2 Source Naturals Business Overview
- 6.18.3 Source Naturals Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Source Naturals Acetylglucosamine Product Portfolio
- 6.18.5 Source Naturals Recent Developments
- 6.19 NutriCology
- 6.19.1 NutriCology Company Information
- 6.19.2 NutriCology Business Overview
- 6.19.3 NutriCology Acetylglucosamine Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 NutriCology Acetylglucosamine Product Portfolio
- 6.19.5 NutriCology Recent Developments
7 North America by Country
- 7.1 North America Acetylglucosamine Sales by Country
- 7.1.1 North America Acetylglucosamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Acetylglucosamine Sales by Country (2021-2026)
- 7.1.3 North America Acetylglucosamine Sales Forecast by Country (2027-2032)
- 7.2 North America Acetylglucosamine Market Size by Country
- 7.2.1 North America Acetylglucosamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Acetylglucosamine Market Size by Country (2021-2026)
- 7.2.3 North America Acetylglucosamine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Acetylglucosamine Sales by Country
- 8.1.1 Europe Acetylglucosamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Acetylglucosamine Sales by Country (2021-2026)
- 8.1.3 Europe Acetylglucosamine Sales Forecast by Country (2027-2032)
- 8.2 Europe Acetylglucosamine Market Size by Country
- 8.2.1 Europe Acetylglucosamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Acetylglucosamine Market Size by Country (2021-2026)
- 8.2.3 Europe Acetylglucosamine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Acetylglucosamine Sales by Country
- 9.1.1 Asia-Pacific Acetylglucosamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Acetylglucosamine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Acetylglucosamine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Acetylglucosamine Market Size by Country
- 9.2.1 Asia-Pacific Acetylglucosamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Acetylglucosamine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Acetylglucosamine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Acetylglucosamine Sales by Country
- 10.1.1 South America Acetylglucosamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Acetylglucosamine Sales by Country (2021-2026)
- 10.1.3 South America Acetylglucosamine Sales Forecast by Country (2027-2032)
- 10.2 South America Acetylglucosamine Market Size by Country
- 10.2.1 South America Acetylglucosamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Acetylglucosamine Market Size by Country (2021-2026)
- 10.2.3 South America Acetylglucosamine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Acetylglucosamine Sales by Country
- 11.1.1 Middle East and Africa Acetylglucosamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Acetylglucosamine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Acetylglucosamine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Acetylglucosamine Market Size by Country
- 11.2.1 Middle East and Africa Acetylglucosamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Acetylglucosamine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Acetylglucosamine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Acetylglucosamine Value Chain Analysis
- 12.1.1 Acetylglucosamine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Acetylglucosamine Production Mode & Process
- 12.2 Acetylglucosamine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Acetylglucosamine Distributors
- 12.2.3 Acetylglucosamine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst